Because of both their limited effects on tumor growth and the systemic effects on the immune system linked to the chronicity of treatments performed using mTOR inhibitors, research for the identification of new therapeutic strategies is moving forward (Figure 3). The gene discussed is MTOR; the disease is neoplasm.